Live Analysis: CEOs of Pfizer, Merck, AbbVie and others in the Senate face the price of medicine

The rise in drug prices will be in the spotlight, as evidenced by leaders of the pharmaceutical industry before the Senate Finance Committee on Tuesday. Lawmakers are expected to question company executives such as Merck & Co. and Pfizer Inc. about their pricing practices and their methods of countering competition from generic competitors at lower cost. Senator Chuck Grassley (R., Iowa), chairman of the committee, warned CEOs before the hearing not to "try to blame everyone except themselves."

Here is an article presenting an overview of the audience. And here's how the …